Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 69751-69800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06492863
Gene Therapy(FT-003) for Wet AMD
PHASE1/PHASE2Recruiting
78 participants
Started: Aug 15, 2023 · Completed: Oct 15, 2028
1 condition5 sponsors1 location
NCT05969847
Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer
PHASE2Not yet recruiting
72 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06067672
The Patient's First Point of Contact
N/ARecruiting
150 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT05949944
Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
PHASE2Recruiting
39 participants
Started: Aug 15, 2023 · Completed: Jul 10, 2028
2 conditions2 sponsors2 locations
NCT05638555
Lactated Ringers vs Normal Saline in Patients With Acute Pancreatitis: A Bias-Adjusted Meta-analysis
N/ARecruiting
500 participants
Started: Aug 15, 2023 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT06003140
Efficacy of Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, Nigeria
NARecruiting
90 participants
Started: Aug 15, 2023 · Completed: Oct 21, 2024
1 condition2 sponsors1 location
NCT05511987
Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients
NARecruiting
140 participants
Started: Aug 15, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT06697977
Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease
NAActive, not recruiting
28 participants
Started: Aug 15, 2023 · Completed: Feb 28, 2025
7 conditions1 sponsor1 location
NCT06025630
Targeting Endoplasmic Reticulum Stress in Human Hypertension
PHASE1/PHASE2Recruiting
70 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06076356
Effects of Foam Roller Versus KT Tape on Delayed Onset Muscle Soreness
NAActive, not recruiting
24 participants
Started: Aug 15, 2023 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT06014736
A Phase I Study of XJ101 in Chinese Healthy Subjects
PHASE1Active, not recruiting
38 participants
Started: Aug 15, 2023 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT06184490
Prone Position With Different Types of Cushions in Patients With ARDS
NARecruiting
12 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05681858
Plaque Burden and Ischemia in MINOCA
N/ARecruiting
100 participants
Started: Aug 15, 2023 · Completed: Aug 31, 2027
1 condition3 sponsors1 location
NCT06086808
Effect Of Resistance Training On Physical Fitness, Cognitive Ability, And Academic Performance In Young Adults
NARecruiting
20 participants
Started: Aug 15, 2023 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT06063356
Effects of Dextrose Prolotherapy in Patients With Knee Osteoarthritis
NAActive, not recruiting
66 participants
Started: Aug 15, 2023 · Completed: Jun 20, 2024
1 condition1 sponsor1 location
NCT05806203
A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment
NARecruiting
60 participants
Started: Aug 15, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05983237
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05946460
Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
PHASE2Recruiting
22 participants
Started: Aug 15, 2023 · Completed: Jul 10, 2025
1 condition1 sponsor1 location
NCT06290024
A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data
N/ARecruiting
2,000 participants
Started: Aug 15, 2023 · Completed: Jul 15, 2025
1 condition1 sponsor1 location
NCT05418972
A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma
PHASE2Recruiting
20 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2035
1 condition2 sponsors1 location
NCT06019832
Analysis of Stem and Non-Stem Tibial Component
NAEnrolling by invitation
54 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2031
3 conditions1 sponsor1 location
NCT05862272
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
PHASE3Recruiting
1,000 participants
Started: Aug 14, 2023 · Completed: Sep 30, 2030
2 conditions1 sponsor120 locations
NCT06004986
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
PHASE4Recruiting
216 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors2 locations
NCT04798612
Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression
PHASE2Recruiting
68 participants
Started: Aug 14, 2023 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05993429
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
N/ARecruiting
200 participants
Started: Aug 14, 2023 · Completed: Aug 1, 2027
4 conditions10 sponsors1 location
NCT05987982
Mouth Odor on Preventing Pneumonia by Oral Frailty
NARecruiting
304 participants
Started: Aug 14, 2023 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05945901
A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer
PHASE2/PHASE3Recruiting
606 participants
Started: Aug 14, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05883293
Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis
EARLY_PHASE1Active, not recruiting
7 participants
Started: Aug 14, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06545851
Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training
NARecruiting
15 participants
Started: Aug 14, 2023 · Completed: Nov 30, 2024
2 conditions1 sponsor1 location
NCT05963633
Future Thinking to Improve Parent-Child Relationships
NAEnrolling by invitation
72 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06066827
Hair Regeneration in Androgenetic Alopecia
NAActive, not recruiting
60 participants
Started: Aug 14, 2023 · Completed: Nov 30, 2023
1 condition3 sponsors2 locations
NCT05875207
Physical Therapy Integrated With Mindfulness for Patients With Chronic Pain and Opioid Treatment
NARecruiting
45 participants
Started: Aug 14, 2023 · Completed: Nov 30, 2025
4 conditions3 sponsors2 locations
NCT05694624
Investigations Into Sepsis-associated Acute Kidney Injury
N/ARecruiting
20 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05667649
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
PHASE1Recruiting
18 participants
Started: Aug 14, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06394557
Evaluation of In-office Bleaching-induced Sensitivity With 2 or 7 Days Interval Between Sessions
NAActive, not recruiting
47 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05893940
Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
NARecruiting
75 participants
Started: Aug 14, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05824923
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
PHASE3Recruiting
264 participants
Started: Aug 14, 2023 · Completed: Feb 28, 2027
8 conditions39 sponsors1 location
NCT05979363
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia
PHASE2Recruiting
20 participants
Started: Aug 14, 2023 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT06001268
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
NARecruiting
80 participants
Started: Aug 14, 2023 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06002100
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
N/AEnrolling by invitation
540 participants
Started: Aug 14, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor10 locations
NCT06479421
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
N/ARecruiting
250 participants
Started: Aug 14, 2023 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT06036095
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
PHASE4Recruiting
260 participants
Started: Aug 14, 2023 · Completed: Mar 15, 2027
4 conditions1 sponsor1 location
NCT05292989
A Personalised Approach Utilising the Frailty Index to Empower Consumers
NARecruiting
200 participants
Started: Aug 14, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06213064
A Direct-to-Consumer Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults
N/ARecruiting
58 participants
Started: Aug 14, 2023 · Completed: Jun 1, 2024
1 condition2 sponsors1 location
NCT04203316
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation
PHASE2Active, not recruiting
1 participants
Started: Aug 14, 2023 · Completed: Oct 3, 2026
2 conditions2 sponsors28 locations
NCT06227793
Pragmatic Clinical Trial to Assess the Effectiveness of Pharmaceutical Intervention in Patients With Uncontrolled Asthma
NARecruiting
76 participants
Started: Aug 14, 2023 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT06085976
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
PHASE2Recruiting
62 participants
Started: Aug 14, 2023 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT04419272
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
PHASE4Recruiting
226 participants
Started: Aug 14, 2023 · Completed: Sep 30, 2027
1 condition5 sponsors4 locations
NCT05803941
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
PHASE4Recruiting
700 participants
Started: Aug 14, 2023 · Completed: Jul 21, 2033
1 condition1 sponsor54 locations